Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System

Seeking Alpha / 2 Views

Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic* vertebrogenic low back pain. PORTAGE, Mich., May 19, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced that its OptaBlate...

Comments